MX9206073A - Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen - Google Patents

Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Info

Publication number
MX9206073A
MX9206073A MX9206073A MX9206073A MX9206073A MX 9206073 A MX9206073 A MX 9206073A MX 9206073 A MX9206073 A MX 9206073A MX 9206073 A MX9206073 A MX 9206073A MX 9206073 A MX9206073 A MX 9206073A
Authority
MX
Mexico
Prior art keywords
hydroxyriptamine
receptor
pharmaceutical compositions
compositions containing
antagonist compounds
Prior art date
Application number
MX9206073A
Other languages
English (en)
Spanish (es)
Inventor
Francis David King
Laramie Mary Gaster
Graham Francis Joiner
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122623A external-priority patent/GB9122623D0/en
Priority claimed from GB929205427A external-priority patent/GB9205427D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9206073A publication Critical patent/MX9206073A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9206073A 1991-10-24 1992-10-22 Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen MX9206073A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919122623A GB9122623D0 (en) 1991-10-24 1991-10-24 Pharmaceuticals
GB929205427A GB9205427D0 (en) 1992-03-12 1992-03-12 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9206073A true MX9206073A (es) 1993-04-01

Family

ID=26299737

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206073A MX9206073A (es) 1991-10-24 1992-10-22 Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Country Status (6)

Country Link
EP (1) EP0609278A1 (fr)
JP (1) JPH07500588A (fr)
AU (1) AU2752692A (fr)
MX (1) MX9206073A (fr)
PT (1) PT100994A (fr)
WO (1) WO1993008187A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
AU4081393A (en) * 1992-05-23 1993-12-30 Smithkline Beecham Plc Medicaments for the treatment of anxiety
WO1994000113A2 (fr) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments renfermant des antagonistes du recepteur de 5-ht¿4?
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
JPH08502283A (ja) * 1992-10-16 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用の縮合環系ｎ−アルキルピペリジニル−４−メチルカルボン酸エステル／アミド
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
GB9314973D0 (en) * 1993-07-20 1993-09-01 Smithkline Beecham Plc Medicaments
AUPP433398A0 (en) * 1998-06-25 1998-07-16 Australian National University, The Compounds and processes
WO2008005908A2 (fr) 2006-07-07 2008-01-10 Forest Laboratories Holdings Limited Dérivés de pyridoïmidazole
EP2120938A4 (fr) * 2006-12-20 2010-12-08 Merck Sharp & Dohme Analogues de l'imidazopyridine en tant que modulateurs du récepteur de cb2, utilisables pour le traitement de la douleur et des maladies respiratoires et non respiratoires
JP2016028016A (ja) * 2012-12-12 2016-02-25 大日本住友製薬株式会社 オキサジアゾール誘導体とその医薬用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782107T2 (de) * 1986-07-25 1993-04-01 Beecham Group Plc Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
EP0289170B1 (fr) * 1987-04-25 1993-06-23 Beecham Group Plc Composés azabicycliques, leur procédé de préparation et compositions pharmaceutiques les contenant
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists

Also Published As

Publication number Publication date
PT100994A (pt) 1994-01-31
WO1993008187A1 (fr) 1993-04-29
JPH07500588A (ja) 1995-01-19
EP0609278A1 (fr) 1994-08-10
AU2752692A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
MX9204786A (es) Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene.
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
MX9202545A (es) Derivados biciclicos de rapamicina y composicion farmaceutica que los contiene.
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
MX9203576A (es) Derivados de 3-amido pirazol y composiciones farmaceuticas que los contienen.
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
MX9101873A (es) Derivados de bencimidazol e imidazoles substituidos con bencimidazol e indol y composiciones farmaceuticas que los contienen
MX9202289A (es) Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9202623A (es) Compuestos de indol y composiciones farmaceuticas que los contienen.
NO934800D0 (no) Anvendelse av tetrahydrokarbazonderivater som 5HT1-reseptoragonis ter
MX9100317A (es) Nuevos compuestos de beta-lactama,procedimiento para su preparacion y composiciones farmaceuticas que los contienen
MX9202910A (es) Nuevos derivados de dihidropiridina y composicion farmaceutica que los contiene.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
MX9204563A (es) Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende.
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
MX9206073A (es) Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen
MX9201710A (es) Carbamatos de rapamicina y composicion farmaceutica que los contiene.
ATA240692A (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
FI923163A (fi) Foerfarande foer taetning av fogar i byggnader
DK495089A (da) Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler
MX9206075A (es) Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen